Precision Therapeutics Announces Record STREAMWAY® System Sales in the First Three Months of 2018

Sixteen STREAMWAY Systems sold in Q1 2018, compared with five units sold in Q4 2017 and three sold in Q1 2016 MINNEAPOLIS, March 29, 2018 (GLOBE NEWSWIRE) Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the Company”), today provided a sales update from its Skyline Medical division, producer of the FDA-approved STREAMWAY System for automated, direct-to-drain medical fluid disposal. Skyline Medical sold 16 STREAMWAY Systems in the first quarter of 2018, to a combination of both new customers as well as its existing The post Precision Therapeutics Announces Record STREAMWAY® System Sales in the First Three Months of 2018 appeared first on Public Wire.
http://bit.ly/2GhSZZj